Joseph J. Manning - Sep 8, 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: EXECUTIVE VICE PRESIDENT
Signature: /s/ Joseph J. Manning by Jessica H. Paik, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: Sep 8, 2022
Transactions value $: -$1,440,301
Form type: 4
Date filed: 9/9/2022, 05:27 PM
Previous filing: Aug 26, 2022
Next filing: Feb 22, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$1.02M	+23K	+43.21%	$44.40	76.3K	Sep 8, 2022	Direct
transaction	ABT	Common shares without par value	Sale	-$2.46M	-23K	-30.17%	$107.00	53.2K	Sep 8, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-23K	-100%	$0.00^*	0	Sep 8, 2022	Common Shares	23K	$44.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).